Dr. Glassman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 W 8th Ave
Ste 1400
Spokane, WA 99204Phone+1 866-747-2455Fax+1 509-227-7070
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2020 - 2024
UT Health Graduate School of Biomedical SciencesM.S., Cancer Biology, 2020 - 2022- Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2016 - 2020
University of Washington School of MedicineClass of 2016
Certifications & Licensure
TX State Medical License 2020 - 2026
WA State Medical License 2024 - 2026
RI State Medical License 2016 - 2020
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Cancer Answers Scholarship 2022
- Linda K. Manning Endowed Fellowship in Ovarian Cancer 2020
- Recognition of Excellence in Minimally Invasive Gynecology AAGL, 2020
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsTargeting CCR2macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer.Yutuan Wu, Nicholas B Jennings, Yunjie Sun, Santosh K Dasari, Emine Bayraktar
Journal of Cancer Research and Clinical Oncology. 2022-04-01 - 5 citationsEndothelial p130cas confers resistance to anti-angiogenesis therapy.Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran, Alpa M Nick, Elaine Stur
Cell Reports. 2022-01-25 - 8 citationsRational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.Katelyn F. Handley, Cristian Rodriguez-Aguayo, Shaolin Ma, Elaine Stur, Robiya Joseph
Molecular Cancer Therapeutics. 2021-09-28
Research History
- Research FellowDr. Sood laboratory. Research focus: overcoming adaptive resistance to anti-angiogenic therapy in ovarian cancer2020 - 2022
Professional Memberships
- Fellow
- Member
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
